https://clinicaltrials.gov/ct2/show/NCT03517566?type=Intr&cond=Eczema&phase=0124&lupd_s=09%2F17%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
DESCRIPTION:
Condition: Atopic Dermatitis
Interventions: Drug: Placebo; Drug: ZPL389
Sponsor: Novartis Pharmaceuticals
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03517566
FIRST POSTED:
Mon, 07 May 2018 12:00:00 EDT
LAST UPDATE POSTED:
10/01/19 07:03AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03517566?type=Intr&cond=Eczema&phase=0124&lupd_s=09%2F17%2F2019&lupd_d=14&sort=nwst